|
C16ORF75 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.12970008084801E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.73069999995523E-06 |
| Normal-vs-Stage2 |
5.842100E-02 |
| Normal-vs-Stage3 |
3.565200E-04 |
| Normal-vs-Stage4 |
3.855800E-02 |
| Stage1-vs-Stage2 |
8.959200E-01 |
| Stage1-vs-Stage3 |
1.885580E-02 |
| Stage1-vs-Stage4 |
1.354220E-01 |
| Stage2-vs-Stage3 |
3.739700E-02 |
| Stage2-vs-Stage4 |
1.388420E-01 |
| Stage3-vs-Stage4 |
6.826200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.59029994623228E-09 |
| Normal-vs-AfricanAmerican |
3.52460000000443E-05 |
| Normal-vs-Asian |
1.198400E-02 |
| Caucasian-vs-AfricanAmerican |
5.886800E-01 |
| Caucasian-vs-Asian |
7.349200E-01 |
| AfricanAmerican-vs-Asian |
8.246000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.07910000116618E-08 |
| Normal-vs-Female |
1.93089999989127E-07 |
| Male-vs-Female |
3.194200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.762500E-03 |
| Normal-vs-Extreme_Weight |
1.370490E-04 |
| Normal-vs-Obese |
2.49049999956341E-07 |
| Normal-vs-Extreme_Obese |
2.460600E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.175800E-01 |
| Normal_Weight-vs-Obese |
4.025200E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.147200E-01 |
| Extreme_Weight-vs-Obese |
9.414500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.336600E-01 |
| Obese-vs-Extreme_Obese |
1.491030E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.303900E-03 |
| Normal-vs-Age(41-60Yrs) |
5.58339999789936E-08 |
| Normal-vs-Age(61-80Yrs) |
2.91760000048491E-07 |
| Normal-vs-Age(81-100Yrs) |
6.852200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.036400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.779630E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.217900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.522570E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.737000E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.461900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.95510000200861E-08 |
| Normal-VS-Type2 PRCC |
2.776700E-03 |
| Normal-VS-KIRP CIMP |
2.02269999999283E-05 |
| Normal-VS-Unclassified PRCC |
4.005600E-04 |
| Type1 PRCC-VS-Type2 PRCC |
2.736800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.22044604925031E-16 |
| Type1 PRCC-VS-Unclassified PRCC |
5.777600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.56261678543979E-12 |
| Type2 PRCC-VS-Unclassified PRCC |
6.566000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.58259999999811E-05 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.029620E-02 |
| Normal-vs-N1 |
1.040050E-04 |
| Normal-vs-N2 |
1.964620E-01 |
| N0-vs-N1 |
1.855460E-03 |
| N0-vs-N2 |
9.936300E-02 |
| N1-vs-N2 |
6.030400E-01 |
|
|
